Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon
Gut
.
2024 Mar 7;73(4):573-581.
doi: 10.1136/gutjnl-2023-330596.
Authors
Christopher D Byrne
#
1
,
Giovanni Targher
#
2
,
Herbert Tilg
#
3
Affiliations
1
Human Development and Health, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK c.d.byrne@soton.ac.uk.
2
Metabolic Disease Research Unit, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella (VR), Italy.
3
Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University, Innsbruck, Innsbruck, Austria.
#
Contributed equally.
PMID:
38233199
DOI:
10.1136/gutjnl-2023-330596
No abstract available
Keywords:
NONALCOHOLIC STEATOHEPATITIS.
Publication types
Review
MeSH terms
Humans
Thyroid Hormone Receptors beta*
Substances
Thyroid Hormone Receptors beta